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The importance of adequate intervention descriptions in minimising research waste and 
improving research useability and reproducibility has gained attention in the last few years. 
Nearly all focus to date has been on intervention reporting in randomised trials. Yet 
clinicians are encouraged to use systematic reviews, whenever available, rather than single 
trials to inform their practice. This article explores the problem and implications of 
incomplete intervention details during the planning, conduct, and reporting of systematic 
reviews and makes recommendations for review authors, peer reviewers and journal editors.  
Up to 60% of interventions in trial reports are inadequately described, although more information is 
sometimes available after contacting authors.1 When interventions are inadequately described in 
randomised trials, clinicians and patients have to guess how to use effective interventions and 
researchers are unable to replicate or build upon the research. Another consequence of inadequately 
described interventions in trial reports is that the intervention details are not available to the authors 
of systematic reviews. Few studies have examined the problem of inadequate intervention 
description in systematic reviews. In an analysis of 58 systematic reviews of stroke interventions,2 
most reviews were missing information for the majority of items that are needed to make an 
intervention description adequate. For example, details such as the intervention procedure, 
materials, fidelity, and tailoring were missing from more than 80% of reviews. Inadequate 
intervention reporting in trials not only produces avoidable waste for the original trials but is 
compounded in downstream uses of the trials such as in systematic reviews - with implications for 
the reproducibility and useability of the systematic review. 
Appropriate use of intervention details in the planning, conduct, and reporting of systematic reviews 
is facilitated if interventions are well described in trials and other evaluative studies. To assist 
authors to comprehensively describe interventions, the Template of Intervention Description and 
Replication (TIDieR) checklist and guide was developed and published in 2014, with an initial 
focus on helping authors of trials.3 Historically, the development of systematic review techniques, 
methods, and technologies has focused on aspects such as searching, assessing and reporting risk of 
bias, and statistical methods. The clinical useability of the results of systematic reviews has had less 
attention, and intervention use and reporting in reviews almost none.4  
To identify a common approach for improving the consideration and reporting of intervention 
details in systematic reviews a group of systematic review authors, trial authors, journal editors, 
methodologists, and statisticians with expertise in intervention descriptions, reporting guidelines, 
trials, and systematic reviews attended a 1-day meeting in Oxford in June 2016. Representatives 
from the following groups also attended: the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) group,5 the Cochrane Library, the EQUATOR Network, the Template of 
Intervention Description and Replication (TIDieR) group,3 the Evidence for Policy and Practice 
Information and Coordinating (EPPI) Centre, and the NIHR Journals Library. The meeting 
organisers (TH, PG) invited participants, drafted the agenda, invited presentations, and collected 
and disseminated background literature. The day consisted of stimulus presentations on key relevant 
topics and associated research. Each presentation was followed by group discussion during which 
detailed records about the discussion points and possible recommendations and implications for 
systematic reviews were made. In the final session of the day, the draft recommendations were 
discussed and modified collaboratively until group consensus was attained. Following the meeting, 
the group (authors of this paper) refined these recommendations, focusing on wordsmithing, during 
the writing of the paper.   
Recommendations to improve the consideration of interventions when planning, 
conducting, and reporting systematic reviews 
The Box contains recommendations that authors of systematic reviews should undertake to improve 
the consideration of interventions when planning, conducting, and reporting their reviews. 
Following the list of recommendations is an elaboration and explanation of each. The 
recommendations are applicable to all systematic reviews of studies of intervention effectiveness, 
including Cochrane reviews and non-Cochrane reviews. Suggestions specific to either Cochrane 
reviews or non-Cochrane reviews are detailed later in this section. For most systematic reviews, 
many of the recommendations also apply to the comparator intervention with these details needing 
appropriate consideration and reporting.   
Box. Recommendations for authors to improve the consideration of interventions when 
planning, conducting, and reporting systematic reviews 
Planning the review 
1. Consider intervention details during question formulation  
Use TIDieR3 to identify any important details of the intervention that will determine the 
questions that the review will address, including how broad or narrow the review should 
be, and what the main comparison will be.  
2. Describe intervention considerations in the review protocol  
Describe the intervention and relevant components (if multi-component) and 
characteristics of it in the protocol. Relevant protocol sections may include: the review 
question, background, search terms, eligibility criteria, data items, and quantitative 
synthesis plans.   
Conducting the review 
3. Extract intervention details as part of data extraction 
Use TIDieR as a guide to the essential intervention characteristics to include in the data 
extraction form and extract accordingly. 
4. Request missing intervention details  
When feasible, request missing intervention details from the authors using TIDieR as a 
guide to which details to request, and note when details are not available.  
5.  Consider intervention characteristics during statistical analyses and exploration of 
heterogeneity when appropriate 
     Where appropriate and feasible, consider intervention characteristics as specified in the 
protocol when grouping studies, conducting analyses, and exploring heterogeneity. 
Reporting the review 
6. Report intervention details in a summary table  
Provide a table that summarises the intervention details for each study (see template in 
web extra 1, and example in Table 1).  
7. Share intervention materials where possible  
Where intervention materials are available, share or provide their location details in the 
review’s intervention summary table.  
8. Describe implications for future research  
     If the summary of intervention details revealed important gaps in existing research, or if 
the analyses identified a significant association between effect and the presence or 
absence of intervention components or characteristics, describe the future research 
implications of this in the review.  
 
Recommendation 1 – Consider intervention details during question formulation 
As many systematic review authors use a PICO format to design their review question, decisions 
about the I (intervention) part (and where necessary, its characteristics; and if a multi-component 
intervention, the major components) should be given as much consideration as the other parts. 
Authors should use TIDieR to identify any important details of the intervention that should 
determine the questions that the review will address, for example, which active components are 
used, the timing of the intervention, the dose, the mode of delivery, or who provides the 
intervention. Such details will also help to inform the breadth of the review. If a scoping exercise 
was performed as part of the planning of the review, summarising the intervention details (such as 
in a summary table, see Table 1) from studies located during the scoping exercise may help inform 
this decision. Authors should also carefully consider intervention details when deciding on the main 
comparison that will be made in the review.  
Recommendation 2 - Describe intervention considerations in the review protocol  
When registering a systematic review title (such as at PROSPERO; 
www.crd.york.ac.uk/PROSPERO/) and writing a protocol, authors should carefully consider and 
describe the intervention and relevant components (if multi-component) and characteristics of it. 
Items in the reporting guideline for systematic review protocols (PRISMA-P) that are particularly 
relevant to this include: Items 7 (explicit statement of the review question), 8 (eligibility criteria), 
10 (search strategy), 12 (data items), and 15a (criteria for quantitative synthesis).6  Further details 
about sections of the protocol relevant to intervention details are provided below:  
Background: If relevant, protocol authors should report how consideration of details of the 
intervention affected the scope of the review and categorisation of interventions within this 
scope. Where relevant, authors should also clarify why differences in the details of the 
intervention might modify its effects - for example, which active components are used, the 
timing of the intervention, the dose, the mode of delivery, or who provides the intervention. 
Objectives: Intervention details may determine the main comparisons that will be made and 
should be considered when deciding on the review’s objectives. 
Eligibility criteria: Intervention details may be part of inclusion or exclusion criteria and should 
be clearly stated. When intervention details in potentially eligible studies are not stated or not 
clear, this step in a review can be compromised.  
Data extraction: Protocols should include plans for collecting sufficient details about the 
interventions so that they can be described adequately. TIDieR items can be used as a guide to 
which intervention characteristics should be incorporated into the data extraction form. 
Missing information: Because trial reports often do not adequately describe interventions but 
trial authors can often provide missing details,1,7 at the protocol stage, review authors should 
plan to request missing intervention details from the investigators. 
Statistical analyses, such as subgroup, dose-response, and meta-regression: Decisions about 
appropriate inclusion and grouping of studies for analyses often requires knowledge of the 
characteristics of the interventions that were studied. When there is a reason to believe that 
differences in intervention characteristics (for example, the dose) might lead to different effects, 
these differences should be identified in the protocol, together with the basis for the assumptions 
they might modify the effect of the intervention, the expected direction of effect modification, 
and a plan for undertaking a subgroup analysis or sensitivity analysis. In network meta-analyses, 
creating nodes can be difficult if the interventions are not sufficiently described. 
Recommendation 3 - Extract intervention details as part of the data extraction process 
As specified in the protocol, during the data extraction stage, review authors should extract details 
of the essential intervention characteristics (guided by TIDieR items) for each included study. to 
include. 
 
Recommendation 4 - Request missing intervention details 
If, after extracting intervention details from the primary studies and other available sources (such as 
online supplements or trial websites), intervention details are missing, review authors should 
request the missing details from the authors where feasible. When review authors attempted to 
contact trial authors and did not receive a response or intervention details were unable to be shared, 
this should be noted in the review. This will alert readers of the review that intervention details are 
unlikely to be available and this may inform their choice of intervention and also save them from 
trying to obtain details in vain.  
 
Recommendation 5 - Consider intervention characteristics during statistical analyses and 
exploration of heterogeneity when appropriate 
When considering reasons for heterogeneity, having sufficient information about the characteristics 
of the interventions evaluated may be very important. Where appropriate, decisions about grouping 
studies and conducting analyses should incorporate knowledge of intervention details as specified in 
the protocol. 
 
Recommendation 6 - Report intervention details in a summary table 
Review authors should provide a table that summarises the intervention details for each study (see 
example in Table 1 and the blank table provided as a template in web extra 1). The column 
headings are based on the TIDieR items. A summary table serves a few purposes, including to: 
assist readers to compare the characteristics of the interventions and consider those that may be 
feasible for implementation in their setting; highlight interventions that have missing or unavailable 
details; show which trials did not specify certain characteristics as part of the intervention; and 
highlight characteristics that have not been studied in existing trials. Review authors should list all 
trials and not omit from the table trials that provided evidence that a certain intervention was not 
effective. Knowing the details of an intervention that was not effective may inform future research. 
Moreover, it is helpful for readers to know that a particular implementation of the intervention in a 
specific context or when compared to a specific control did not work (context may be particularly 
important for non-drug interventions).  
 
Recommendation 7 - Share intervention materials  
During the review process, review authors may gather intervention materials (for example, 
informational materials provided as part of the intervention) from trial authors. Intervention 
materials are the most commonly missing element of intervention descriptions,1 even though 
interventions cannot be faithfully implemented without them. If review authors have obtained 
permission to do so, these materials should be deposited in online repositories (such as Figshare, 
Dryad, Open Science Framework or OpenTrials), or in online supplementary materials of the 
review, and their availability and location indicated in the intervention details table in the review.  
Recommendation 8 - Describe implications for future research  
Review authors should summarise the intervention details of included studies (such as in a 
summary table as suggested in Recommendation 6). If this summary reveals important gaps in 
existing research - for example, if no or few interventions used a particular component (for multi-
component interventions) or dose/intensity or delivery method, this should inform the future 
research section of reviews. Similarly, if analyses conducted within the review identify that 
particular characteristics or components of the intervention were (or were not) significantly 
associated with effect, this is also useful to inform future research. Most of the time, the 
heterogeneity in effect sizes that may be explained by one or more specific characteristics of an 
intervention is not definitive as such assessments are generally confounded by other study features. 
Also in the discussion section of the review, authors should consider and justify the extent to which 
the review findings support conclusions about whether any of the differences in intervention details 
lead to important differences in effects.8,9 
 
Cochrane reviews 
Authors of Cochrane intervention reviews are expected to follow the Methodological Expectations 
for Cochrane Intervention Reviews (MECIR). The revised MECIR standards released in October 
201610 now reference TIDieR as a guide when collecting and reporting intervention characteristics 
(Standards C44 and R65). Information about TIDieR has also been added to Cochrane author 
training materials.11 Cochrane authors are encouraged to provide a structured account of 
intervention details in the table of ‘Characteristics of included studies’. They are also able to 
provide an additional summary table with intervention details for each study (as shown in Table 1, 
which comes from a Cochrane review12), and share intervention materials gathered during the 
review (see Recommendation 7, Box) as appendices to the review.   
[insert Table 1 about here – see end of paper] 
Non-Cochrane reviews 
Authors of non-Cochrane reviews are encouraged to follow the recommendations listed in the Box. 
The relevant PRISMA-P items are listed earlier in the elaboration of Recommendation 2. The 
relevant PRISMA items include: item 1 (title), 2 (abstract), 3 (rationale), 4 (objectives), 6 
(eligibility criteria), 8 (search), 9 (study selection), 10 (data collection process), 11 (data items), 18 
(study characteristics), 25 (limitations), and 26 (conclusion and future research). Modification of 
guidance for the relevant PRISMA5 and PRISMA-P6 items will be considered when these reporting 
guidelines are next updated.  
Recommendations for peer reviewers and editors of systematic reviews: As with other research 
replicability and reporting issues, peer reviewers and editors also have a role to play in helping to 
ensure that interventions are appropriately considered and reported in systematic reviews. They 
should be guided by many of the recommendations in the Box and check that interventions are 
clearly defined and intervention details are appropriately considered in analyses, reported as 
completely as possible, and considered in the review’s discussion, conclusions, and where 
appropriate, the future research section.  
Using the findings of a systematic review: the importance of knowing 
intervention details  
New trials should be designed according to what is already known from systematic reviews.13 
Providing complete intervention descriptions in systematic reviews is important for informing 
researchers as they develop and modify interventions to evaluate in future studies (see 
Recommendation 8).  
Clinicians, patients, and policymakers cannot implement effective interventions if details of the 
interventions are not known. Review users should be able to compare the details of the interventions 
and consider whether and, if so, how to implement interventions in their setting (see details in the 
elaboration of Recommendation 6, and section below). As well as individual decisions, having 
appropriate intervention details may also influence broader decisions such as those about 
reimbursement or adapting standard practices. The useability of many downstream evidence 
resources that incorporate systematic review findings (such as clinical guidelines, patient decision 
aids) is also influenced by whether the interventions are appropriately detailed in the review. The 
safety of an intervention can also be compromised if there is not transparency about all its 
characteristics.   
Choosing which intervention to implement 
It is not our intention to provide guidance about methods for selecting interventions for clinical 
implementation from those included in a systematic review. Such decisions need to be informed by 
multiple considerations14 including: the size of the desirable effects; the size of the undesirable 
effects; the balance between the desirable and undesirable effects (considering patients’ preferences 
and how much people value the main outcomes); the certainty of the evidence; resource 
requirements; cost-effectiveness; impacts on equity; and intervention feasibility, acceptability, and 
availability of intervention details. Because these considerations go beyond the evidence that is 
included in most systematic reviews and as there is no optimal method of selecting a particular 
intervention from those included in a review, in most circumstances it is not appropriate for review 
authors to nominate a single recommended intervention. Details of approaches for choosing an 
intervention are described elsewhere.14,15 However, all of the approaches require detailed 
descriptions of the intervention, and some of them also require detailed descriptions of the 
comparator interventions.  
 
Although review authors generally should not make recommendations about a single intervention, 
they may wish to provide a summary paragraph of the known considerations when choosing an 
intervention. This may be particularly helpful if users of the review choose to follow a ‘single-trial-
based choice’ approach.15 In this approach, users of the review examine the trials and consider the 
effects (benefits and harms) and risk of bias of single studies; then consider the context, feasibility 
and requirements of the various interventions. A summary table of intervention details (such as in 
the example in Table 1) may assist the user with this step. While the information that needs to be 
considered and summarised will obviously depend on the intervention being reviewed, an example 
of the broad content that a summary paragraph in a review might include is: “Among the [number 
of] trials, there are [number of] trials that have a low risk of bias and have sufficiently described 
interventions. All of these involved [list common characteristics], but there are a number of 
variations to consider, depending on ….[cost, time, risk of harms, training requirements, 
availability,…..].”   
Further research  
Many aspects of using and reporting intervention details in systematic reviews need further 
research. For example, studies should explore various methods for reporting intervention details, 
and for incorporating intervention details into forest plots so that effect sizes, risk of bias, and 
intervention characteristics (and availability of intervention details) can be considered 
simultaneously. Incorporating intervention details into the conduct and presentation of overviews 
and network meta-analyses16 also needs exploring. The extent to which review authors make 
changes to the scope of eligible interventions (and how broad or narrow this is) as reviews progress 
from registration, to protocol, to a published review is not known. More complete intervention 
reporting at each of these stages of a systematic review is necessary to progress this research 
agenda. Research with end-users of reviews (including clinicians, patients, guideline developers, 
and policy makers) to better understand how they use review results and which details influence 
their choice when deciding between interventions would also be valuable. Further research is also 
needed into approaches, such as Qualitative Comparative Analysis17 and logic models,18 for 
identifying which configurations of intervention characteristics and contextual features19 are critical 
for successful outcomes.  
Conclusion 
Improving the completeness of intervention descriptions in systematic reviews is likely to be a cost-
effective contribution towards facilitating evidence implementation from reviews and reducing the 
research waste that is caused by reviews failing to consider and provide sufficient details about the 
interventions. With implications for being able to reproduce and implement systematic reviews, all 
of those with a role in producing, reviewing, and publishing systematic reviews should commit to 
helping to solve this remediable barrier.  
 
Summary points      
 Intervention details are rarely fully considered or completely reported in systematic reviews, 
limiting the reproducibility and useability of systematic reviews – this is wasteful. 
 Intervention details are needed in many stages of the review process – from question 
formulation, to decisions about eligibility and analyses, to results interpretation, and use of 
the review findings.  
 Systematic review authors should give careful consideration to intervention details during 
the planning, conduct, and reporting of the review, including extracting, requesting and fully 
reporting them.  
 Improving the consideration and description of interventions in systematic reviews, such by 
providing a summary table with details, will likely contribute to reducing avoidable waste in 
health research. 
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Table 1    Example of table summarising intervention details (for each TIDieR item3) in a systematic review (from Coxeter et al12) 
 
Author 
Year 
Brief name Recipient Why What 
(materials) 
What 
(procedures) 
Who 
provided 
How Where When and how 
much 
Tailoring Modifica
tion of 
intervent
ion 
througho
ut trial 
Strategie
s to 
improve 
or 
maintain 
intervent
ion 
fidelity  
Extent of 
interventi
on fidelity  
Altiner 
2007 
Complex 
GP peer-led 
educational 
intervention 
GPs and 
patients 
Focused on 
communication within 
a consultation and the 
mutual discordance 
between patients' 
expectations and 
doctors' perceived 
patient expectations, 
empowering patients 
to raise the issue 
within the 
consultation. By 
'informing' both sides 
in the consultation, it 
is hoped that doctors 
and patients would 
openly talk about the 
issue and thus reduce 
unnecessary antibiotic 
prescriptions. 
Peers used a 
semi-structured 
dialogue script 
for outreach 
visits. 
Patient 
materials 
(leaflet and 
poster) provided 
in waiting room 
primarily 
focused on the 
patients' role 
doctor-patient 
'antibiotic 
misunderstandin
g' and brief 
evidence-based 
information on 
acute cough and 
antibiotics. 
GP peer-led 
outreach visits. 
Peers were 
trained to 
explore GPs' 
'opposite' 
motivational 
background to 
address their 
beliefs and 
attitudes. GPs 
were motivated 
to explore 
patient 
expectations 
and demands, to 
elicit anxieties 
and make 
antibiotic 
prescribing a 
subject in the 
consultation 
Patient 
materials were 
aimed at 
empowering 
patients to raise 
and clarify 
issues within 
the consultation 
5 practising 
GPs and 
teaching 
academics 
in the lead 
authors' 
department 
(2 female, 
33 to 63 
years of 
age); 
trained in 3 
sessions for 
outreach 
visits 
Face-to-face 
outreach 
visits to GPs 
GP clinics 
during normal 
working 
hours 
1 outreach visit 
performed per GP 
(duration not 
specified) 
Not 
described 
Not 
described 
Not 
described 
51/52 GPs 
received 
interventio
n 
Briel 
2006 
Brief 
training 
programme 
in patient-
centred 
communica
tion 
GPs Focused on teaching 
GPs how to 
understand and modify 
patients' concepts and 
beliefs about the use of 
antibiotics for ARIs. 
GPs were introduced 
to a model (Prochaska 
1992) for identifying 
Evidence-based 
guidelines for 
diagnosis and 
treatment of 
ARIs (updated, 
locally adapted 
and reviewed by 
local experts) 
distributed as a 
GPs were 
trained in 
elements of 
active listening, 
to respond to 
emotional cues, 
and to tailor 
information 
given to 
Not 
specified 
Seminar in 
small groups 
(number not 
specified) and 
personal 
feedback by 
telephone 
prior to the 
start of the 
Not specified Attendance at 1 x 
6-hour seminar 
and 1 x 2-hour 
telephone call to 
give personal 
feedback prior to 
the trial start 
Not 
described 
Not 
described 
Not 
described 
Not 
described 
patients' attitude and 
readiness for 
behaviour change 
booklet [URL 
provided is no 
longer active] 
patients. 
Physicians used 
a model were 
introduced to a 
model 
(Prochaska 
1992) to 
identify 
patients' attitude 
and readiness 
for behaviour 
change 
trial. 
Evidence-
based 
guidelines 
were 
distributed as 
a booklet 
Butler 
2012  
Multifacete
d flexible 
blended 
learning 
approach 
for 
clinicians 
GPs and 
nurse 
practitioner
s 
Blended learning 
experience to develop 
clinicians' sense of the 
importance about 
change and their 
confidence in their 
ability to achieve 
change based on 
Social Learning 
Theory 
Clinicians reflected on 
practice-level 
antibiotic dispensing 
and resistance data, 
reflected on own 
clinical practice 
(context-bound 
learning), and were 
trained in novel 
communication skills 
derived from 
principles of 
motivational 
interviewing 
Summaries of 
research 
evidence and 
guidelines, web-
based modules 
using video-rich 
material 
presenting 
novel 
communication 
skills, and a 
web-based 
forum to share 
experiences and 
views (see 
www.stemming
thetide.org for 
online 
component) 
Intervention 
consist of 7 
components: 
experiential 
learning, 
updated 
summaries of 
research 
evidence and 
guidelines; 
web-based 
learning in 
novel 
communication 
skills; practising 
consulting skills 
in routine care; 
facilitator-led 
practice-based 
seminar on 
practice-level 
data on 
antibiotic 
prescribing and 
resistance; 
reflections on 
own clinical 
practice, and a 
web-based 
forum to share 
experiences and 
views 
A 
facilitator 
conducted 
the face-to-
face 
seminar 
Intervention 
consisted of 7 
parts (5 
online 
modules, 1 
face-to-face 
seminar and 1 
facilitator-led 
practice-
based 
seminar) 
The face-to-
face and 
facilitator-led 
seminars 
were 
presented at 
the general 
practice 
7 components (5 
online, 1 face-to-
face and 1 
facilitator-led 
practice-based 
seminar) 
A booster module 
(6 to 8 months 
after completion 
of initial training) 
reinforced these 
skills 
Interventio
n was 
flexible so 
clinicians 
could 
access the 
online 
components 
and try out 
new skills 
with their 
patients at 
their 
convenienc
e 
Not 
described 
Not 
described 
138/139 
completed 
all online 
training 
and 
uploaded 
description
s of 
consultatio
ns for the 
portfolio 
tasks; 
129/139 
attended 
the 
practice-
based 
seminars; 
76/139 
completed 
the 
optional 
booster 
session at 
6 months; 
11/139 
entered 
new 
threads on 
the online 
forum with 
81 posts 
and 1485 
viewings 
of posts 
and 
threads 
Cals 
2009 
Enhanced 
communica
GPs Focused on 
information exchange 
based on the elicit-
Pre and post-
workshop 
transcripts of 
Brief context-
learning based 
workshop in 
Experience
d 
moderator 
Brief 
workshop (5 
to 8 GPs), 
General 
practice 
1 x 2-hour 
moderator-led 
small groups 
Not 
described 
Not 
described 
Not 
described 
66% of 
patients 
recruited 
tion skills 
training 
provide-elicit 
framework from 
counselling in 
behaviour change - 
exploring patients' 
fears and expectations, 
patients' opinion on 
antibiotics and 
outlining the natural 
duration of cough in 
lower respiratory tract 
infections 
simulated 
patients 
small groups (5 
to 8 GPs), 
preceded and 
followed by 
practice-based 
consultations 
with simulated 
patients. GPs 
reflected on 
own transcripts 
of consultations 
with simulated 
patients, which 
were also peer-
reviewed by 
colleagues 
to lead 
seminars 
preceded and 
followed by 
practice-
based 
consultation 
with 
simulated 
patients 
workshop, 
preceded and 
followed by 
practice-based 
consultation with 
simulated patients 
by GPs 
allocated 
to training 
in 
enhanced 
communic
ation skills 
recalled 
their GP's 
use at least 
3 of 4 
specific 
communic
ation skills 
compared 
with 19% 
in the no 
training 
group 
Francis 
2009 
Interactive 
booklet for 
parents and 
clinician 
training in 
its use 
GPs and 
patients 
Focused on specific 
communication skills, 
such as exploring 
parent's main 
concerns, asking about 
their expectations, and 
discussing prognosis, 
treatment options and 
reasons that should 
prompt re-consultation 
8-page booklet 
(now at 
www.whenshou
ldIworry.com); 
online training 
in use of the 
booklet 
included videos 
to demonstrate 
use of the 
booklet within a 
consultation, as 
well as audio 
feeds, pictures 
and links to 
study materials 
[original URL 
no longer 
active] 
Booklet given 
to parents to use 
in the 
consultation and 
as a take-home 
resource (no 
further details 
provided) 
Online training 
on the use of the 
booklet was 
provided to 
GPs: describing 
the content and 
aims of the 
booklet, and 
encouraging use 
within the 
consultation to 
facilitate use of 
specific 
communication 
skills 
N/A (online 
training) 
Parents used 
the booklet 
face-to-face 
in the 
consultation 
with GPs and 
took it home; 
GP training in 
use of booklet 
was online 
General 
practice; 
parents' 
homes 
1 x 40-minute 
online training 
module 
Not 
described 
Not 
described 
Online 
clinician 
training 
monitore
d through 
study 
website: 
whether a 
GP has 
logged 
on to the 
site, how 
much 
time 
spent on 
it and 
which 
pages 
were 
viewed 
Stated that 
treatment 
fidelity 
was not 
measured 
so that 
assessors 
could 
remain 
blind to 
the study 
group 
Légaré 
2012 
Shared 
decision 
making 
training 
program 
(DECISIO
N+2) 
Family 
physicians 
(including 
teachers 
and 
residents) 
A shared decision 
making training 
program that aimed to 
help physicians 
communicate to 
patients the probability 
of a bacterial ARI and 
the benefits and harms 
Online tutorial 
and workshop 
included videos, 
exercises and 
decision aids to 
help physicians 
communicate to 
their patients 
Online self 
tutorial 
comprising 5 
modules 2-hour 
online tutorial 
followed by a 
facilitator-led 
on-site 
Trained 
facilitators 
Online 
tutorial and 
face-to-face 
workshop 
Family 
practice 
teaching units 
1 x 2-hour online 
tutorial, followed 
by 1 x 2-hour on-
site interactive 
workshop. 
Participants had 1 
month to complete 
the programme 
Not 
described 
Not 
described 
Not 
described 
Of the 162 
physicians, 
103 
completed 
both the 
online 
tutorial 
and 
associated with the use 
of antibiotics 
the probability 
of bacterial 
ARIs and 
benefits/harms 
of antibiotic 
use. Decision 
aids were 
available in the 
consultation 
rooms in all 
family practice 
teaching units 
interactive 
workshops 
aimed to help 
physicians 
review and 
integrate 
concepts 
acquired during 
online training 
workshop; 
16 
completed 
only the 
workshop; 
15 only 
the 
tutorial; 
and 28 
completed 
none of 
the 
training 
component
s 
Légaré 
2011 
Multiple-
component, 
continuing 
professiona
l 
developme
nt program 
in shared 
decision 
making 
(DECISIO
N+) 
Family 
medicine 
groups 
(physicians 
and nurses) 
Aimed to help family 
physicians 
communicate to 
patients the probability 
of bacterial ARI and 
benefits and harms of 
antibiotic use 
Workshops 
included videos 
(simulated 
consultations of 
usual care and 
SDM) and 
exercises 
(facilitators and 
barriers to 
SDM). GPs 
trained in the 
use of 5 
decision support 
tools using 
video examples 
and group 
exercises. A 
booklet 
summarising 
workshop 
content 
provided to 
participants. 
Postcard 
reminders sent 
Interactive 
workshops and 
related material, 
reminders of 
expected 
behaviours and 
GP feedback on 
agreement 
between their 
decisional 
conflict and that 
of their patients 
Trained 
facilitators 
Face-to-face 
workshop 
Family 
medicine 
groups 
3 x 3-hour 
interactive 
workshops and 
related material, 
in addition to 
reminders of 
expected 
behaviours and 
GP feedback on 
agreement 
between their 
decisional conflict 
and that of their 
patients. 
DECISION+ 
conducted over 4 
to 6 months 
Not 
described 
4 pilot 
workshop
s held 
rather 
than 3 as 
the 
second 
workshop 
was 
redesigne
d and re-
piloted 
after 
feedback 
on its 
first 
testing 
Not 
described 
Not 
described 
Little 
2013 
Internet-
based 
training in 
enhanced 
communica
tion skills 
GPs Rationale was that 
Internet-based training 
can be more widely 
disseminated than 
face-to-face training. 
Training focused on 
eliciting patients' 
expectations and 
concerns, natural 
disease course, 
treatments, agreement 
on a management plan, 
Interactive 
booklet for use 
by GPs within 
consultations 
Training 
supported by 
video 
demonstrations 
of consultation 
techniques 
Online modules 
and an 
interactive 
booklet for use 
within 
consultations. 
(Group 
practices also 
appointed a lead 
GP to organise 
a structured 
meeting on 
N/A (online 
modules) 
other than 
lead GP at 
each 
practice to 
organise a 
meeting 
(not 
specific to 
just this 
arm of the 
Online 
modules (and 
GP-led 
structured 
practice-
based 
meeting) 
General 
practice 
Internet modules 
completed alone 
or in a group 
Not 
described 
Not 
described 
Not 
described 
94/108 
practices 
(87%) 
completed 
the 
communic
ation 
training. 
Mean (SD) 
time spent 
on the 
website 
summing up and 
guidance on when to 
re-consult 
prescribing 
issues) 
intervention 
though) 
was 37 
(29) 
minutes 
Welsche
n 2004 
Group 
education 
meeting 
with 
consensus 
procedure 
and 
communica
tion skills 
training 
GPs/pharm
acists and 
their 
assistants, 
and patients 
GPs discussed 
evidence for antibiotic 
benefit/risk, and 
learned 
communication 
techniques to explore 
patients' expectations 
and concerns, inform 
about natural course of 
symptoms, self- 
medication and alarm 
symptoms. Patient 
education provided 
information on the 
self- limiting nature or 
ARIs, self-medication 
and alarm symptoms 
requiring re-
consultation 
Group 
consensus 
guidelines and 
patient waiting 
room materials 
(poster/leaflets) 
Group 
education 
meeting with 
consensus 
procedure, with 
a summary, and 
guidelines 
mailed 1 month 
later to 
reinforce 
consensus 
reached; 
feedback on 
prescribing 
behaviour (post- 
and pre-
intervention 
insurance 
claims data) and 
practice-level 
reporting of 
extent 
prescribing 
behaviours 
aligned with 
consensus 
reached; group 
education 
session for GP 
and pharmacists 
assistants 
(Dutch 
guidelines and 
skills training in 
patient 
education); 
waiting room 
education al 
material for 
patients 
Jointly led 
by GP and 
pharmacist 
Group 
education 
meeting for 
GPs with 
consensus 
procedure and 
communicatio
n skills 
training, 
Group 
education for 
GPs' and 
pharmacists' 
assistants, 
monitoring 
and feedback 
on 
prescribing 
behaviour, 
and patient 
education 
materials 
Not described 1 x group 
education meeting 
with consensus 
procedure; 1 x 2-
hour group 
education session 
for GP and 
pharmacists' 
assistants; 
monitoring and 
feedback of 
prescribing 
behaviour at 6 
months post-
intervention 
Not 
described 
Not 
described 
Not 
described 
Not 
described 
 
ARI: acute respiratory infection; GP: general practitioner; N/A: not applicable; SDM: shared decision making 
